{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:13:14Z","timestamp":1791184394916,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.pharmthera.2013.02.002","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T19:02:06Z","timestamp":1360868526000},"page":"409-417","source":"Crossref","is-referenced-by-count":27,"title":["Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension"],"prefix":"10.1016","volume":"138","author":[{"given":"Matthew","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Ciuclan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2013.02.002_bb0510","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/CIRCULATIONAHA.109.927681","article-title":"Formation of plexiform lesions in experimental severe pulmonary arterial hypertension","volume":"121","author":"Abe","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2013.02.002_bb0515","doi-asserted-by":"crossref","first-page":"L500","DOI":"10.1152\/ajplung.00049.2012","article-title":"Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice","volume":"303","author":"Abid","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0370","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1183\/09031936.00010409","article-title":"Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females","volume":"34","author":"Austin","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0290","doi-asserted-by":"crossref","DOI":"10.1186\/ar2495","article-title":"A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation","volume":"10","author":"Beretta","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2013.02.002_bb0275","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood-2010-05-285973","article-title":"Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function","volume":"117","author":"Burton","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0400","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201103-0412OC","article-title":"A novel murine model of severe pulmonary arterial hypertension","volume":"184","author":"Ciuclan","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2013.02.002_bb0415","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.201206-1028OC","article-title":"Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression","volume":"187","author":"Ciuclan","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0475","unstructured":"clinical trials.gov. Information from clinical trials.gov'., 2008. Ref Type: Online Source."},{"issue":"6","key":"10.1016\/j.pharmthera.2013.02.002_bb0270","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1182\/blood-2012-02-413047","article-title":"Platelets can enhance vascular permeability","volume":"120","author":"Cloutier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0095","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/01.RES.0000216858.04599.e1","article-title":"Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells \u2014 role of 5-HT2A receptors, caveolin-1, and K(V)1.5 channel internalization","volume":"98","author":"Cogolludo","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0255","doi-asserted-by":"crossref","first-page":"L604","DOI":"10.1152\/ajplung.00309.2011","article-title":"BMP type II receptor deficiency confers resistance to growth inhibition by TGF-beta in pulmonary artery smooth muscle cells: role of proinflammatory cytokines","volume":"302","author":"Davies","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0170","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1378\/chest.08-1341","article-title":"Molecular mechanisms of pulmonary arterial hypertension role of mutations in the bone morphogenetic protein type II receptor","volume":"134","author":"Davies","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0325","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20101629","article-title":"Platelet-derived serotonin links vascular disease and tissue fibrosis","volume":"208","author":"Dees","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjp.2008.241","article-title":"Pulmonary hypertension: therapeutic targets within the serotonin system","volume":"155","author":"Dempsie","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0055","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1161\/CIRCULATIONAHA.108.767558","article-title":"Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice","volume":"117","author":"Dempsie","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0395","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-12-159","article-title":"Development of pulmonary arterial hypertension in mice over-expressing S100A4\/Mts1 is specific to females","volume":"12","author":"Dempsie","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0080","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1165\/rcmb.2010-0412OC","article-title":"Molecular signature of a right heart failure program in chronic severe pulmonary hypertension","volume":"45","author":"Drake","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0485","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1183\/09031936.00126010","article-title":"Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats","volume":"37","author":"Dumitrascu","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0125","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0761-8425(06)71561-3","article-title":"Serotonin and pulmonary arterial hypertension","volume":"23","author":"Eddahibi","year":"2006","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0195","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1161\/CIRCULATIONAHA.105.591321","article-title":"Cross talk between endothelial and smooth muscle cells in pulmonary hypertension \u2014 critical role for serotonin-induced smooth muscle hyperplasia","volume":"113","author":"Eddahibi","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-7-1","article-title":"Upregulated genes in sporadic, idiopathic pulmonary arterial hypertension","volume":"7","author":"Edgar","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/thx.54.2.161","article-title":"Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension","volume":"54","author":"Egermayer","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0520","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJM196711232772101","article-title":"Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with carcinoid syndrome","volume":"277","author":"Engelman","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0525","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2353\/ajpath.2006.050599","article-title":"Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte\/macrophage lineage","volume":"168","author":"Frid","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0455","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/j.1552-4604.1995.tb05013.x","article-title":"Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease","volume":"35","author":"Frishman","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0210","doi-asserted-by":"crossref","first-page":"L527","DOI":"10.1152\/ajplung.00091.2011","article-title":"Myoendothelial gap junctional signaling induces differentiation of pulmonary arterial smooth muscle cells","volume":"301","author":"Gairhe","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0410","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201001-0123OC","article-title":"Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy","volume":"182","author":"Ghofrani","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0120","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1161\/CIRCULATIONAHA.104.524926","article-title":"Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats","volume":"111","author":"Guignabert","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0150","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/rccm.200805-691OC","article-title":"RhoA and Rho kinase activation in human pulmonary hypertension role of 5-HT signaling","volume":"179","author":"Guilluy","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0355","first-page":"3440","article-title":"Cytochrome P4501B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity","volume":"60","author":"Hanna","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","article-title":"Increased plasma serotonin in primary pulmonary-hypertension","volume":"99","author":"Herve","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0165","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.107.736801","article-title":"Genetic ablation of the Bmpr2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension","volume":"118","author":"Hong","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/bj3110353","article-title":"Structure and function of the aromatic amino-acid hydroxylases","volume":"311","author":"Hufton","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0075","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0330","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ahj.2007.08.014","article-title":"Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension","volume":"155","author":"Hunter","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0335","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pharmthera.2011.03.008","article-title":"Serotonin receptors and heart valve disease \u2014 it was meant 2B","volume":"132","author":"Hutcheson","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.108.180976","article-title":"Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy","volume":"104","author":"Jaffre","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0385","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/cvr\/27.9.1619","article-title":"Role of 5-hydroxytryptamine in the progression of monocrotaline-induced pulmonary-hypertension in rats","volume":"27","author":"Kanai","year":"1993","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0100","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/hh2401.100426","article-title":"Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension \u2014 converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B\/1D-receptor antagonist GR127935","volume":"89","author":"Keegan","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0220","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3382\/ps.2011-01919","article-title":"Intrapulmonary arteries respond to serotonin and adenosine triphosphate in broiler chickens susceptible to idiopathic pulmonary arterial hypertension","volume":"91","author":"Kluess","year":"2012","journal-title":"Poult Sci"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0240","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1182\/blood-2011-06-358374","article-title":"Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension","volume":"119","author":"Launay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.RES.0000176025.57706.1e","article-title":"Interdependent serotonin transporter and receptor pathways regulate S100A4\/Mts1, a gene associated with pulmonary vascular disease","volume":"97","author":"Lawrie","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0155","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1096\/fj.06-8058com","article-title":"The 5-HT transporter transactivates the PDGFbeta receptor in pulmonary artery smooth muscle cells","volume":"21","author":"Liu","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0180","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1096\/fj.08-127910","article-title":"Serotonin induces Rho\/ROCK-dependent activation of Smads 1\/5\/8 in pulmonary artery smooth muscle cells","volume":"23","author":"Liu","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.RES.0000141428.53262.a4","article-title":"Rho kinase-induced nuclear translocation of ERK1\/ERK2 in smooth muscle cell mitogenesis caused by serotonin","volume":"95","author":"Liu","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0315","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1165\/rcmb.2010-0078OC","article-title":"Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells","volume":"44","author":"Liu","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0175","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.RES.0000215809.47923.fd","article-title":"Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice","volume":"98","author":"Long","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0280","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/000331979304400905","article-title":"Circulating platelet aggregates indicative of in-vivo platelet activation in pulmonary-hypertension","volume":"44","author":"Lopes","year":"1993","journal-title":"Angiology"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.155.3759.217","article-title":"Tryptophan hydroxylation \u2014 measurement in pineal gland brainstem and carcinoid tumor","volume":"155","author":"Lovenber","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0435","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1164\/rccm.200509-1365OC","article-title":"Genetic association of the serotonin transporter in pulmonary arterial hypertension","volume":"173","author":"Machado","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0165-6147(99)01389-9","article-title":"Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action?","volume":"20","author":"MacLean","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coph.2009.02.005","article-title":"Serotonin and pulmonary hypertension \u2014 from bench to bedside?","volume":"9","author":"MacLean","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-60761-500-2_20","article-title":"The serotonin hypothesis of pulmonary hypertension revisited","volume":"661","author":"MacLean","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0115","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1161\/01.CIR.0000127375.56172.92","article-title":"Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension","volume":"109","author":"MacLean","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0105","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/sj.bjp.0704273","article-title":"Increased contractile response to 5-hydroxytryptamine1-receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergy","volume":"134","author":"MacLean","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0445","doi-asserted-by":"crossref","first-page":"552S","DOI":"10.1378\/chest.128.6_suppl.552S","article-title":"Serotonin transporter and receptors in various forms of human pulmonary hypertension","volume":"128","author":"Marcos","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0460","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0167-5273(87)90200-2","article-title":"Acute hemodynamic-response to the S2-serotonergic receptor antagonist, ketanserin, in patients with primary pulmonary-hypertension","volume":"14","author":"Mcgoon","year":"1987","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0345","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/CIRCULATIONAHA.105.554667","article-title":"Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice","volume":"113","author":"Mekontso-Dessap","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0200","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000252210.58849.78","article-title":"Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension","volume":"49","author":"Morecroft","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/cvr\/cvp306","article-title":"In vivo effects of a combined 5-HT1B receptor\/SERT antagonist in experimental pulmonary hypertension","volume":"85","author":"Morecroft","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0530","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2012.70","article-title":"Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension","author":"Morecroft","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0085","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0305","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.pupt.2006.08.007","article-title":"P38 MAP kinase: essential role in hypoxia-mediated human pulmonary artery fibroblast proliferation","volume":"20","author":"Mortimer","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0285","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pharmthera.2004.08.005","article-title":"Functions of 5-HT2A receptor and its antagonists in the cardiovascular system","volume":"104","author":"Nagatomo","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0375","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00109-009-0524-6","article-title":"The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle","volume":"88","author":"Piao","year":"2010","journal-title":"J Mol Med JMM"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0380","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00109-010-0679-1","article-title":"Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure","volume":"88","author":"Piao","year":"2010","journal-title":"J Mol Med JMM"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0465","unstructured":"Press releases, Predix, 7, 16 Aug & 8 Dec 2006 & EPIX, 7 Aug 2007 & 15 May 2008; Form 10-K, EPIX, 2008. 2012. Ref Type: Online Source."},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0265","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1378\/chest.11-0793","article-title":"Inflammation in pulmonary arterial hypertension","volume":"141","author":"Price","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0035","doi-asserted-by":"crossref","first-page":"L662","DOI":"10.1152\/ajplung.1999.277.3.L662","article-title":"Dexfenfluramine increases pulmonary smooth muscle intracellular Ca2+ independent of membrane potential","volume":"277","author":"Reeve","year":"1999","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0160","doi-asserted-by":"crossref","first-page":"L486","DOI":"10.1152\/ajplung.00237.2010","article-title":"Serotonin transporter interacts with the PDGFbeta receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells","volume":"300","author":"Ren","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2006.08.050","article-title":"Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension","volume":"550","author":"Rochefort","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0040","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.CIR.100.8.869","article-title":"Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates \u2014 implications for primary pulmonary hypertension","volume":"100","author":"Rothman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0015","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017735","article-title":"Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension","volume":"6","author":"Rothman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0405","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","article-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition","volume":"115","author":"Schermuly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0340","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/335254a0","article-title":"Serotonin stimulates Dna-synthesis in fibroblasts acting through 5-Ht 1B receptors coupled to A Gi-protein","volume":"335","author":"Seuwen","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0425","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1378\/chest.08-2823","article-title":"Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension","volume":"136","author":"Shah","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12013-011-9156-x","article-title":"Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels","volume":"61","author":"Shen","year":"2011","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0260","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.healun.2012.01.575","article-title":"Incidence of major and minor mechanical driveline failure in continuous flow left ventricular assist devices","volume":"31","author":"Stephenson","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1742-1241.2009.02232.x","article-title":"Endothelial progenitor cells in pulmonary hypertension \u2014 dawn of cell-based therapy?","volume":"64","author":"Toshner","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0235","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/rccm.200810-1662OC","article-title":"Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension","volume":"180","author":"Toshner","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0020","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0006-2952(00)00306-3","article-title":"Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors","volume":"59","author":"Ulus","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0505","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0006-2952(03)00556-2","article-title":"A unique central tryptophan hydroxylase isoform","volume":"66","author":"Walther","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.1078197","article-title":"Synthesis of serotonin by a second tryptophan hydroxylase isoform","volume":"299","author":"Walther","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0390","first-page":"269","article-title":"5-HT1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats","volume":"22","author":"Wang","year":"2001","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0145","doi-asserted-by":"crossref","first-page":"L863","DOI":"10.1152\/ajplung.00281.2009","article-title":"JNK regulates serotonin-mediated proliferation and migration of pulmonary artery smooth muscle cells","volume":"298","author":"Wei","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0320","doi-asserted-by":"crossref","first-page":"L1273","DOI":"10.1152\/ajplung.00082.2012","article-title":"Serotonylated fibronectin is elevated in pulmonary hypertension","volume":"302","author":"Wei","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0030","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.CIR.94.9.2216","article-title":"Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction","volume":"94","author":"Weir","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0310","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.200302-264OC","article-title":"Proliferation and signaling in fibroblasts \u2014 role of 5-hydroxytryptamine(2A) receptor and transporter","volume":"170","author":"Welsh","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.pharmthera.2013.02.002_bb0365","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCULATIONAHA.111.062927","article-title":"Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension","volume":"126","author":"White","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0360","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1152\/physiolgenomics.00249.2010","article-title":"Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH","volume":"43","author":"White","year":"2011","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0440","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1164\/rccm.200509-1361OC","article-title":"Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension","volume":"173","author":"Willers","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0250","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1634\/stemcells.2007-0048","article-title":"Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34(+) stem\/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis","volume":"25","author":"Yang","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.pharmthera.2013.02.002_bb0300","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.yjmcc.2012.02.004","article-title":"Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin","volume":"52","author":"Ziu","year":"2012","journal-title":"J Mol Cell Cardiol"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725813000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725813000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T15:27:44Z","timestamp":1562686064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725813000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0163725813000302"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2013.02.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718015335.793479772","asserted-by":"object"}]},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}